
Next in Pharma: The 2025 Outlook—The Future is Now
Discover key insights from PwC's 2025 pharma outlook on AI innovation, patent cliffs, strategic resilience, and navigating global market disruptions.
Co-hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
Listen in to PwC Next in Health podcast conversations here or follow our series Apple Podcasts, Spotify, YouTube Music and more.
Discover key insights from PwC's 2025 pharma outlook on AI innovation, patent cliffs, strategic resilience, and navigating global market disruptions.
Discover key insights from PwC's 2025 healthcare outlook on AI, policy shifts, and resilience amid rising costs, competition, and Medicare & Medicaid-driven growth.
PwC deals leaders Roel van den Akker and Nick Donkar provide insights into M&A in 2024 and offer a preview of what lies ahead.
PwC's U.S. Healthcare Climate Survey reveals key insights into healthcare organizations' climate strategies, disparities across sectors, sustainability perceptions, and the impact on human health.